Skip to main content

Table 1 Baseline patient characteristics

From: Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Patient Characteristic Number of Patients (%)
Male:Female Ratio 16:8
Average Age (range) years 62 (26-79)
Primary Site  
Parotid 17 (71%)
Submandibular 3 (13%)
Minor - Base of Tongue 2 (8%)
Minor - Sphenoid Sinus 1 (4%)
Minor - Ethmoid Sinus 1 (4%)
Histology  
Adenoid Cystic Carcinoma 5 (21%)
Mucoepidermoid Carcinoma 5 (21%)
Adenocarcinoma 3 (13%)
Squamous Cell Carcinoma 3 (13%)
Poorly Differentiated Carcinoma 3 (13%)
Carcinoma Ex-pleomorphic Adenoma 2 (8%)
Myoepithelial Carcinoma 1 (4%)
Salivary Duct Carcinoma 1 (4%)
Anaplastic Carcinoma 1 (4%)
T-Stage  
1 1 (4%)
2 8 (33%)
3 6 (25%)
4a 7 (29%)
4b 2 (8%)
N-Stage  
0 6 (25%)
1 3 (13%)
2a 0
2b 14 (58%)
2c 1 (4%)
3 0
Stage  
II 1 (4%)
III 2 (8%)
IVA 19 (79%)
IVB 2 (8%)